NORTHERN DEANERY REGIONAL MRCPsych COURSE Psychosis and Substance Misuse Module Year II Module Leader: Dr Niraj Ahuja March – May 2012 Location: Jubilee Theatre, St. Nicholas Hospital 1 CONTENTS Page 1. 2. 3 4 5 Introduction 3 List of Teachers 4 Timetable 5 Psychosis: Psychosocial and Legal Aspects 1.1 Stigma and Social Exclusion 1.1.1 Module Objectives 1.1.2 Reading List 1.1.3 Lesson Plan 1 1.2 User and Carer Perspective 1.2.1 Module Objectives 1.2.2 Reading List 1.2.3 Lesson Plan 2 1.3 Principles of Mental Health Legislation 1.3.1 Module Objectives 1.3.2 Reading List 1.3.3 Lesson Plan 3 Patient-Level Interventions in Psychosis 2.1 Cognitive Behaviour Therapy in Psychosis 2.1.1 Module Objectives 2.1.2 Reading List 2.1.3 Lesson Plans 4, 5 and 6 Neuropsychology, Recovery and Models of Community Provision 3.1 Neuropsychology of Schizophrenia 3.1.1 Module Objectives 3.1.2 Reading List 3.1.3 Lesson Plan 7 3.2 The Course, Outcome and Recovery 3.2.1 Module Objectives 3.2.2 Reading List 3.2.3 Lesson Plan 8 3.3 The Models of Community Provision for Psychoses 3.3.1 Module Objectives 3.3.2 Reading List 3.3.3 Lesson Plan 9 and 10 Substance Misuse 4.1 Prevalence and Patterns of Use 4.1.1 Module Objectives 4.1.2 Reading List 4.1.3 Lesson Plan 11 4.2 Assessment of Drug and Alcohol Use 4.2.1 Module Objectives 4.2.2 Reading List 4.2.3 Lesson Plan 12 4.3 Treatment Interventions 4.3.1 Module Objectives 4.3.2 Reading List 4.3.3 Lesson Plan 13 Co-morbid Psychosis and Substance Misuse 5.1 Co-morbidity 5.1.1 Module Objectives 5.1.2 Reading List 5.1.3 Lesson Plan 14 5.2 Formulation Workshop 5.2.1 Module Objectives 6 6 7 9 11 12 13 14 15 15 17 18 2/19 Lesson plan 15INTRODUCTION Overall Aims Module Objectives The module objectives for each session are listed in terms of Aims and the desired learning outcome(s). Our overall intention is to briefly review material on schizophrenia, psychosis and substance misuse that has not been covered by the previous teaching earlier in the course. You will have the opportunity to evaluate this module in terms of these learning outcomes in the final session of the module as well as at the end of each section of teaching. MRCPsych Curriculum Please refer to the new curricula issued by the Royal College of Psychiatrists, available on the College website; http://www.rcpsych.ac.uk/training/curriculum2010.aspx. Reading Lists We recommend that the essential reading be done prior to and during the weeks of teaching, for you to get the most out of the teaching programme. The Reading Lists include material that is part of the MRCPsych curriculum but not necessarily being covered in this module. Lesson Plans The lesson plans detail the material to be covered in the Module and the variety of teaching methods to be used. Lesson plans for each session are indicated in a tabular format describing the subject matter, teaching methods and the teacher(s). Please be prepared to join in the discussion and group exercises where indicated. The more you participate, the more you will gain from the course. Local Hospital Teaching The MRCPsych course is not a comprehensive programme of psychiatric teaching. It is designed to supplement educational experience gained in your local hospital, i.e. your own clinical experience, educational and clinical supervision from your consultant(s), and your local postgraduate teaching programme. Self-directed Learning It is obvious that you will not pass the MRCPsych merely by attending the MRCPsych course and your local teaching programme though it they should help you to structure your reading and also help participate in useful interactive discussion. The reading lists indicate additional sources of information to facilitate self-directed learning. 3/19 LIST OF TEACHERS AC Andrew Cole Assistant Medical Director, Consultant Psychiatrist and Honorary Lecturer, North Tyneside General Hospital, North Tyneside AH Andrea Hearn Consultant Psychiatrist, Regional Drug and Alcohol Service, Plummer Court, Newcastle AL Adrian Lloyd Consultant Psychiatrist, North Tyneside General Hospital, North Tyneside; Senior Lecturer, Academic Psychiatry, NGH; Training Programme Director (CT4-6), School of Psychiatry JH John Horne Teaching Fellow, School of Law, Northumbria University; Former Mental Health Act Commissioner; Part-time Legal Member of the Mental Health Review Tribunal service NA Niraj Ahuja Consultant Psychiatrist and Honorary Lecturer, Wallsend CMHT, Sir GB Hunter Memorial Hospital, Wallsend PK Patrick Keown Consultant Psychiatrist, Rehabilitation Psychiatry, and Senior Lecturer, Newcastle University SG Stephen Galvin Consultant Clinical Psychologist Landsdowne Clinic, Newcastle SM Steve Moorhead Consultant Psychiatrist, Regional CBT Centre, Plummer Court and Early Intervention Services, Newcastle & North Tyneside ST Sarah Troughton Associate Specialist, Regional Drug and Alcohol Service, Plummer Court, Newcastle 4/19 TIMETABLE Programme for 28 March 2012 1. Stigma and Social Exclusion PK 09:30 – 10:00 2. User and Carer Perspective PK 10:00 – 11:00 3. Course, Outcome and Recovery in Psychosis NA 11:00 – 13:00 4. CBT in Psychosis – I. Background SM 13:30 – 14:00 5. CBT in Psychosis – II. Formulation and Treatment SM 14:00 – 14:45 6. CBT in Psychosis – III. The Evidence SM 14:45 – 15:30 7. Neuropsychology of Schizophrenia SG 15:30 – 16:30 Programme for 25 April 2012 8. Psychosis and principles of Mental Health Legislation JH/PK 09:30 – 11:30 9. Models of Community Provision – I AC 11:30 – 12:30 10. Models of Community Provision – II AC 12:30 – 13:30 11. Substance Misuse: Patterns of Use AH 14:00 – 14:45 12. Substance Misuse: Assessment AH 14:45 – 15:30 13. Substance Misuse: Treatment/Intervention AH 15:30 – 16:30 AH 09:30 – 10:30 Programme for 09 May 2012 14. Co-morbidity 15. Formulation Workshop 16. Module Evaluation AL/AH/NA/ST NA 10:45 – 12:45 12:45 – 13:15 5/19 1. PSYCHOSIS: PSYCHOSOCIAL AND LEGAL ASPECTS 1.1. Stigma and Social Exclusion 1.1.1. Module Objectives Aims Describe origin(s) of stigma. Identify experience of social exclusion for people with mental health problems. Discuss ways of reducing stigma and promoting social inclusion. Learning Outcome Gain an understanding of the importance of stigma in influencing the use of services and the quality of life for people with mental health problems. 1.1.2. Reading List 1. Biernat M, Dovidio JF (2000). Stigma and stereotypes. In: Eds. Heatherton TF, Kleck RE, Hebl MR, et al. The Social Psychology of Stigma, pp.88-125, Guilford Press, New York. 2. Sartorius N, Schulze H (2005). Reducing the Stigma of Mental Illness: A Report from a Global Programme of the World Psychiatric Association. Cambridge University Press, Cambridge. 1.1.3. Lesson Plan 1 Session 1 Subject Matter Teaching Methods Handout Teacher(s) Interactive session: accounts of experience of stigma and social exclusion by people with mental health problems Small group discussion PK Discuss ways of reducing stigma and promoting social inclusion Small group discussion PK Total = 30 minutes Describe origin(s) of stigma PK 1.2. User and Carer Perspective 1.2.1. Module Objectives Aims To learn about user/carer perspectives on psychiatric service provision through training by users/carers. Demonstrate both similarities and differences in the views of users, carers and professionals with regard to identification of need and provision of services for people with serious mental illnesses. Learning Outcome Understand the important of user and carer involvement in planning, running and monitoring services. Understand the importance of collaborative working with users and carers in determining outcomes relating to recovery, function and quality of life. 1.2.2. Reading List 6/19 1. Barker P, Campbell P, Davidson B (1999). From the Ashes of Experience: Reflections on Madness, Survival and Growth. Whurr Publishers, London. 2. Livingston G, Cooper C (2004). User and carer involvement in mental health training. Advances in Psychiatric Treatment 10: 84-91. 3. Rose D (2001). Users’ Voices: The Perspective of Mental Health Service Users on Community and Hospital Care. Sainsbury Centre for Mental Health, London. 1.2.3. Lesson Plan 2 Session 2 Teaching Methods Presentation by users and/or carers Discussion Subject Matter Demonstrate similarities/differences in views of users, carers and professionals with regard to identification of need and provision of services. Pay particular attention to what users and carers find helpful and unhelpful about contact with psychiatrists. Small group discussion Teacher(s) Users and carers of services 40 minutes PK 20 minutes 1.3. Principles of Mental Health Legislation 1.3.1. Module Objectives Aims Provide an overview of issues relating to the Mental Capacity Act (MCA) and the revised Mental Health Act (MHA), including mental capacity, consent to treatment, and community treatment orders, as applied to psychosis and substance misuse. Learning Outcome Able to identify key issues relating to assessing mental capacity, obtaining informed consent to treatment and application of MCA and MHA to clinical practice in psychosis and substance misuse. 1.3.2. Reading List 1. BMA/Law Society (2010). Assessment of Mental Capacity: A Practical Guide For Doctors and Lawyers. The Law Society/BMA. http://www.bma.org.uk/ethics/consent_and_capacity/assessmentmentalcapacity.jsp 2. Barber P, Brown R, Martin D (2009). Mental Health Law in England and Wales: A Guide for Mental Health Professionals. Learning Matters. 3. CQC (2010). 'Monitoring the use of the MHA in 2009/2010'. The Stationary Office. 4. Department of Health Consent Documents http://www.dh.gov.uk/en/Publichealth/Scientificdevelopmentgeneticsandbioethics/Consent/Co nsentgeneralinformation/index.htm 7/19 5. General Medical Council: Confidentiality: Protecting and Providing Information. http://www.gmc-uk.org/guidance/current/library/confidentiality.asp 6. General Medical Council: Seeking patients’ consent. http://www.gmc-uk.org/guidance/current/library/consent.asp 7. Royal College of Psychiatrists (2004). Council Report CR125. Good Psychiatric Practice. II Ed. http://www.rcpsych.ac.uk/files/pdfversion/cr125.pdf 8. Royal College of Psychiatrists (2006). Council Report CR133. Good Psychiatric Practice: Confidentiality and Information sharing. http://www.rcpsych.ac.uk/files/pdfversion/cr133.pdf 9. DoH (2007). The Mental Capacity Act 2005: The Code of Practice. The Stationary Office. www.justice.gov.uk/docs/mca-cp.pdf 10. DoH (2008). The Mental Health Act 1983: The Code of Practice. The Stationary Office. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidanc e/DH_4005756 11. DoH (2008). The Reference Guide to MHA 1983. The Stationary Office. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidanc e/DH_088162 12. The Mental Health Act Commission http://www.mhac.org.uk/ 1.3.3. Lesson Plan 3 Session 6 Teaching Methods Case discussion (as relevant to psychosis Discussion and substance misuse), with an overview of interspersed issues relating to MCA and MHA, including with didactic consent, capacity and community treatment teaching orders. Subject Matter Teacher(s) PK/JH 120 minutes Interactive 8/19 2. PATIENT LEVEL INTERVENTION IN PSYCHOSIS 2.1. Patient Level Intervention 2.1.1. Module Objectives Aims Present a format for comprehensive needs assessment in a community mental health setting. Discuss the concept of stress vulnerability models in psychosis. Provide a model for bio-psycho-social formulation of case material in psychosis. Provide a framework to understand the place of psychosocial interventions, particularly CBT, in the management of psychosis. Learning Outcome To describe a stress vulnerability model for the development of psychosis. To organise clinical case material into a broad bio-psycho-social as well as CBT formulation. Understand the theoretical basis for CBT interventions in psychosis. Understand the evidence base for effectiveness of psychosocial interventions in psychosis, particularly CBT. Use a bio-psycho-social formulation to generate a multi-modal management plan. 2.1.2. Reading List 1. Barrowclough C, Tarrier N (1997). Families of schizophrenic patients: Cognitive-behavioural interventions. II Ed. Cheltenham, Stanley Thornes. 2. Freeman D, Garety P (2006). Helping patients with paranoid and suspicious thoughts: A cognitive–behavioural approach. Advances in Psychiatric Treatment 12: 404-415. 3. Kingdon D, Turkington D (2002). The Case Study Guide to Cognitive Behaviour Therapy of Psychosis. Chichester, Wiley. 4. Morrison A, Renton JC, Dunn H, Williams S, Bentall RP (2003). Cognitive Therapy for Psychosis: A Formulation-Based Approach. Brunner-Routledge, New York. 5. Romme M, Escher S (1996). Empowering people who hear voices. In: Haddock G, Slade P. Eds. Cognitive Behavioural Interventions with Psychotic Disorders. Routledge. 6. Zubin J, Spring B (1977). Vulnerability: a New View of Schizophrenia. Journal of Abnormal Psychology 86: 103-126. 2.1.3. Lesson Plans 4-6 Session 4 Patient Level Intervention – I – Background Subject Matter Teaching Teacher(s) Methods Theoretical stress vulnerability models Didactic SM 30 minutes Theory of CBT and other psychosocial interventions in psychosis Didactic SM 30 minutes 9/19 Session 5 Patient Level Intervention – II – Formulation and Treatment Subject Matter Teaching Teacher(s) Methods CBT Formulation and Treatment Discussion SM 30 minutes Session 6 Patient Level Intervention – II – The Evidence Subject Matter Teaching Teacher(s) Methods Critical Appraisal of the Evidence Base for Didactic SM CBT interventions in psychosis 30 minutes Discussion SM 15 minutes 10/19 3. NEUROPSYCHOLOGY, RECOVERY AND MODELS OF COMMUNITY PROVISION 3.1. Neuropsychology of Schizophrenia 3.1.1. Module Objectives Aims Present summary of work in neuropsychology of schizophrenia Present how neuropsychological studies link with clinical and brain imaging studies Present clinically useful intervention models to address neuropsychological deficits in schizophrenia Learning Outcome Understand the findings of neuropsychological studies in schizophrenia Describe clinical relevance of neuropsychological deficit in schizophrenia Understand and describe current limitations in neuropsychological studies 3.1.2. Reading List 1. Bilder RM (2009). The Neuropsychology of Schizophrenia Circa 2009. Neuropsychological Review 19: 277-279. 2. Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12: 426-445. 3. Hogarty GE, et al (2004). Cognitive enhancement therapy for schizophrenia: effects of a 2year randomized trial on cognition and behavior. Arch Gen Psychiatry 61: 866-876. 4. Mesholam-Gately, et al (2009). Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuropsychology 23: 315-336. 5. Thompson PM, et al (2001). Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A. 98(20): 11650-11655. 6. Tsuang MT, Stone WS, Faraone SV (2002). Understanding predisposition to schizophrenia: toward intervention and prevention. Can J Psychiatry 47: 518-526. 7. Wood SJ, Allen SB, Pantelis C (2009). Eds. The Neuropsychology of Mental Illness. I Ed. Cambridge University Press. 3.1.3. Lesson Plan 7 Session 7 Teaching Methods Introduction to neuropsychology Didactic Subject Matter Teacher(s) Neuropsychological studies in schizophrenia Didactic Discussion SG 15 minutes SG 30 minutes Treatment options for neuropsychological deficits Didactic Discussion SG 15 minutes 11/19 3.2. The Course, Outcome and Recovery in Schizophrenia and other Psychoses 3.2.1. Module Objectives Aims Present models of understanding the course and outcome in schizophrenia that go beyond the medical model. Present schizophrenia as a bio-psycho-social construct. Summarise data pertaining to outcome in schizophrenia. Present a brief critique of the recovery model of schizophrenia. Learning Outcome Understand the factors affecting outcome and prognosis in schizophrenia. Describe the limitations of the medical rationale guiding treatment of schizophrenia. Describe the limitations of psychiatric practice and emergence of the concept of recovery. 3.2.2. Reading List 1. Bentall RP (1992). Reconstructing Schizophrenia. Routledge. 2. Bentall RP (2004). Madness Explained: Psychosis and Human Nature. Penguin. 3. Care Services Improvement Partnership, Royal College of Psychiatrists & Social Care Institute for Excellence (2007). A Common Purpose: Recovery in Future Mental Health Services (Joint Position Paper 08). Social Care Institute for Excellence. www.scie.org.uk/publications/positionpapers/pp08.pdf 4. Davidson L (2003). Living Outside Mental Illness: Qualitative Studies of Recovery in Schizophrenia. New York University Press, New York. 5. Hopper K, Harrison G, Janca A, Sartorius N (2007). Recovery from Schizophrenia: An International Perspective. Oxford University Press, New York. 6. Warner R (2003). Recovery from Schizophrenia; Psychiatry and Political Economy. III Ed. Routledge. 3.2.3. Lesson Plan 8 Session 8 Teaching Methods Introduction to Recovery Model Didactic Subject Matter Teacher(s) Outcome and Prognosis in schizophrenia Didactic Discussion NA 15 minutes NA 30 minutes Factors influencing the Course and Outcome of schizophrenia Didactic Discussion NA 30 minutes 12/19 3.3. The Models of Community Provision for Psychosis 3.3.1. Module Objectives Aims Describe the focus of service delivery Describe the evolution of community psychiatry from de-institutionalism, to current provision and looking at current/future trends. Examine the evidence-base for current and proposed community psychiatry models. Learning Outcome Understand the context and rationale of developments. Be able to critically appraise these developments. 3.3.2. Reading List 1. Birchwood M, McGorry P, Jackson H (1997). Early Intervention in Schizophrenia. Br J Psychiatry 170: 2-11. 2. Hoult J, Reynolds I, et al (1983). Psychiatric hospitalisation vs. community treatment; the results of a randomised controlled trial. Aust NZ J Psychiatry 17: 160-167. 3. Spencer E, Birchwood M, McGovern D (2001). Management of First Episode Psychosis. Advances in Psychiatric Treatment 7: 133-140. 4. Thornicroft G, Szmukler G (2001). Textbook of Community Psychiatry. Oxford University Press. 3.3.3. Lesson Plans 9-10 Session 9 Subject Matter Teaching Methods Events leading to deinstitutionalisation Didactic Development of Sector Psychiatry and Didactic Community Mental Health Teams Description of role and function of Didactic Specialised Teams Discussion Assertive Outreach Crisis Assessment and Treatment Early Intervention in Psychosis Subject Matter Advantages and specialisation Session 10 Teaching Methods disadvantages of Didactic Discussion Changing role of Psychiatrist Didactic Critical appraisal of the evidence base Didactic Teacher(s) AC 15 minutes AC 15 minutes AC 30 minutes Teacher(s) AC 60 minutes 13/19 14/19 4. SUBSTANCE MISUSE 4.1 Prevalence and Patterns of Use 4.1.1. Module Objectives Aims To describe epidemiology, nature and effects of alcohol and main drugs of abuse. Learning Outcome An understanding of the nature of different drugs of abuse with respect to the context of use from recreation to dependence and direct and indirect consequences of this. 4.1.2. Reading List 1. Ghodse H (1995). Drugs and addictive behaviour: A guide to treatment. Oxford: Blackwell Science. 2. Lishman WA (1997). Toxic Disorders. In: Organic Psychiatry. III Ed. Oxford: Blackwell Science. 3. Winger G, Woods JH, Hofmann FG (2004). A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects. Oxford University Press. 4. Nutt D (1996). Addiction: Brain Mechanisms and their treatment implications. Lancet 347: 3136. 5. Farrel M, Finch E (1999). Aspects of drug use and dependence: Drugs of abuse and addiction. Neurobehavioral Toxicology. Chapter 1: 3-22. 6. http://www.niaaa.nih.gov/ (National Institute on alcohol abuse and alcoholism) 7. NTA (2010). Substance abuse among young people: the 2009-2010 data. http://www.nta.nhs.uk/uploads/nta_substance_misuse_among_yp_0910.pdf 8. NTA (2010). Drug treatment in 2009-2010. http://www.nta.nhs.uk/uploads/nta_annualreport_0910.pdf 4.1.3. Lesson Plan 11 Session 11 Subject Matter Incidence/prevalence/definitions Nature and effects of drug/alcohol Consequences of drug use, direct and indirect Context of use: occasional, experimental, dependence Specific effects e.g. drug induced psychosis / DTs / Alcoholic hallucinosis Teaching Methods Didactic Discussion Teacher(s) AH 45 minutes 15/19 4.2. Assessment of Drug and Alcohol Use 4.2.1. Module Objectives Aims To describe the factors relevant to a comprehensive assessment of drug and alcohol problems. Learning Outcome To be able to adequately assess a patient presenting with drug and/or alcohol misuse with special reference to risk assessment. 4.2.2. Reading List 1. Department of Health (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London. http://www.nta.nhs.uk/areas/clinical_guidance/clinical_guidelines/docs/clinical_guidelines_200 7.pdf 2. Driver and Vehicle Licensing Agency (2005). At a glance guide to medical aspects of fitness to drive. Swansea, DVLA. http://www.dvla.gov.uk/at_a_glance/AAG.SEPT.2005.Final.V2.pdf 3. Heather N, Peters TJ, Stockwell T (2001). Eds. Alcohol Dependence and Problems. Wiley. 4.2.3. Lesson Plan 12 Session 12 Teaching Methods Drug and alcohol history Didactic Confirmation of history (physical, Discussion biochemical, corroboration) Psychiatric/forensic history Family/social history including (child-care issues, protection, etc.) Subject Matter Teacher(s) AH 45 minutes Risk Assessment 1. To self (drug use practices, overdose risk, DSH / suicide, intoxication) 2. To others (domestic violence, child protection issues, property, driving, workplace) Special situations, e.g. pregnancy 4.3. Treatment Interventions 4.3.1. Module Objectives Aims To describe the main treatment interventions used in the field of addiction psychiatry. Learning Outcome To gain an understanding of the main treatment interventions used in addiction psychiatry and the evidence base behind these. 16/19 4.3.2. Reading List 1. Department of Health (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London. http://www.nta.nhs.uk/areas/clinical_guidance/clinical_guidelines/docs/clinical_guidelines_200 7.pdf 2. Miller WR, Heather N (1998). Eds. Treating Addictive Behaviours. II Ed. Plenum Press, New York. 3. Miller W (1983). Motivational Interviewing with Problem Drinkers. Behavioural Psychotherapy 11: 147-172. 4. Ward J, Hall W, Mattick RP (1999). Role of maintenance treatment in opioid dependence. Lancet 353: 221-226. 5. http://www.nta.nhs.uk/ (National Treatment Agency) 6. http://drugs.homeoffice.gov.uk/ (tackling drugs) 7. NTA (2010). Routes to recovery: Psychosocial interventions for drug misuse. A framework and toolkit for implementing NICE-recommended treatment interventions. http://www.nta.nhs.uk/uploads/psychosocial_toolkit_june10.pdf 4.3.3. Lesson Plan 13 Session 13 Subject Matter Teaching Methods Recognising the problem/engagement Didactic Pharmacotherapy, including detoxification, Discussion maintenance treatment, relapse prevention, brief interventions, MET, CBT, 12 step facilitation, relapse prevention etc. Teacher(s) AH 60 minutes 17/19 5. CO-MORBID PSYCHOSIS AND SUBSTANCE MISUSE AND FORMULATION WORKSHOP 5.1. Co-morbidity 5.1.1. Module Objectives Aims Define co-morbidity / dual diagnosis. Discuss how it should be managed and treatment options, with respect to current policy. Learning Outcome Describe the relationship between mental illness and drug and alcohol misuse Understand the various treatment models in co-morbidity. 5.1.2. Reading List 1. Cleary M, Hunt G, Matheson S, et al (2008). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, Issue 1. http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001088/pdf_fs.html 2. Department of Health (2006). Dual diagnosis in mental health inpatient and day hospital settings: Guidance on the assessment and management of patients in mental health inpatient and day hospital settings who have mental ill-health and substance use problems. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidanc e/DH_062649 3. Department of Health (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London. http://www.nta.nhs.uk/areas/clinical_guidance/clinical_guidelines/docs/clinical_guidelines_200 7.pdf 4. Ley A, Jeffrey DP, McLaren S, Seigfried N (2000). Treatment Programmes for people with both severe mental illness and substance misuse (Cochrane Review), in the Cochrane Library 1, Oxford. 5. NTA – Models of Care. http://www.nta.nhs.uk/ 6. Rorstad P, Checinkski K, McGeachy O, Ward M (1996). Eds. Dual Diagnosis; Facing the Challenge. Kenley. Wynne Howard Publishing. 5.1.3. Lesson Plan 14 Session 14 Subject Matter Definitions Diagnosis / formulation Models of disease (social, biological, psychological, context) Care planning and management Co-working / service settings Current policies (DoH and RCPsych) Implications of new MHA Teaching Methods Didactic Teacher(s) AH 60 minutes 18/19 5.2. Formulation Workshop 5.2.1. Module Objectives Aims To integrate skills regarding assessment and management of substance misuse and other psychiatric disorders with an emphasis on psychoses. To facilitate practice at complex formulation skills using case examples that have been developed throughout the psychosis and substance use module. Learning Outcome To improve skills in constructing a broad formulation leading to a comprehensive plan of management. To gain additional understanding of the inter-relationship of substance misuse and psychiatric disorders and to be able to plan further assessment and management of patients with dual diagnosis with increased confidence 5.2.2. Lesson Plan 15 Session 15 Teaching Methods Case discussions building on material Issues on assessment and from previous management of problems of dual teaching diagnosis Subject Matter Advancing case formulation skills Teacher(s) AL/AH/NA/ST 120 minutes 5.2.3. Reading List 1. Abou-Saleh MT (2004). Dual diagnosis: Management within a psychosocial context. Advances in Psychiatric Treatment 10: 352-360. 2. Crome IB, Myton T (2004). Pharmacotherapy in dual diagnosis. Advances in Psychiatric Treatment 10: 413-424. 3. Department of Health (2006). Dual diagnosis in mental health inpatient and day hospital settings: Guidance on the assessment and management of patients in mental health inpatient and day hospital settings who have mental ill-health and substance use problems. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidanc e/DH_062649 4. Department of Health (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London. http://www.nta.nhs.uk/areas/clinical_guidance/clinical_guidelines/docs/clinical_guidelines_200 7.pdf 5. Macleod J (2007). Cannabis use and psychosis: the origins and implications of an association. Advances in Psychiatric Treatment 13: 400-411. 19/19